Following participation in this program, participants will be able to:

• Update knowledge of the new Canadian guidelines for dyslipidemia
• Distinguish and assimilate changes from previous recommendations
• Determine which high-risk patients could benefit from additional lowering of their LDL-C levels
• Integrate therapeutic options into practice

Faculty

John L. Sievenpiper: MD, PhD, FRCPC
Member of the 2021 CCS dyslipidemia guideline 
St. Michael’s Hospital